Detalhe da pesquisa
1.
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
N Engl J Med
; 389(26): 2425-2435, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157500
2.
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Lancet
; 399(10342): 2212-2225, 2022 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691324
3.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet
; 396(10267): 1979-1993, 2021 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220855
4.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Lancet
; 398(10318): 2258-2276, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863358
5.
Point-of-care testing in Paediatric settings in the UK and Ireland: a cross-sectional study.
BMC Emerg Med
; 22(1): 6, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016622
6.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr
; 19(1): 50, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30732648
7.
Fifteen-minute consultation: Chickenpox vaccine-should parents immunise their children privately?
Arch Dis Child Educ Pract Ed
; 104(3): 120-123, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30077987
8.
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Mol Ther
; 25(9): 2104-2116, 2017 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750737
9.
Brief Report: Intravenous fluid prescribing and complications in children in the UK and Ireland.
Acta Paediatr
; 111(7): 1450-1451, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170788
10.
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
J Infect
; 87(3): 230-241, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331429
11.
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
J Infect
; 87(1): 18-26, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085049
12.
Priorities for child health research across the UK and Ireland.
Arch Dis Child
; 107(5): 474-478, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716174
13.
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Lancet Infect Dis
; 22(8): 1131-1141, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550261
14.
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
J Infect
; 84(6): 795-813, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405168
15.
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
J Infect
; 86(5): 540-541, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055303
16.
Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
Ther Adv Respir Dis
; 9(6): 272-80, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341118